At EpiBiologics, a pair of Genentech alumni wants to make next-gen protein degraders

https://www.biopharmadive.com/news/epibiologics-protein-degradation-genentech-ucsf/645514/

Previous
Previous

EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million

Next
Next

EpiBiologics Launches with $50 million Series A Financing to Advance Next-Generation Protein Degradation Platform